CN107308421A - A kind of Chinese medicine composition for treating blood stagnancy due to deficiency of QI type apoplexy sequelae - Google Patents
A kind of Chinese medicine composition for treating blood stagnancy due to deficiency of QI type apoplexy sequelae Download PDFInfo
- Publication number
- CN107308421A CN107308421A CN201710317112.3A CN201710317112A CN107308421A CN 107308421 A CN107308421 A CN 107308421A CN 201710317112 A CN201710317112 A CN 201710317112A CN 107308421 A CN107308421 A CN 107308421A
- Authority
- CN
- China
- Prior art keywords
- parts
- deficiency
- chinese medicine
- medicine composition
- apoplexy sequelae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/69—Polygalaceae (Milkwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a kind of Chinese medicine composition for treating blood stagnancy due to deficiency of QI type apoplexy sequelae, including following component in parts by weight:60 parts of the Radix Astragali, 18 parts of ginseng, 30 parts of jujube kernel, 12 parts of Radix Angelicae Sinensis, 16 parts of radix bupleuri, 20 parts of rattletop of stir-fry, 10 parts of polygala, 16 parts of dried rehamnnia root, 15 parts of the bighead atractylodes rhizome, 12 parts of rubia grass, 10 parts of Exocarpium Citri Rubrum, 8 parts of teasel root, 8 parts of edible tulip, 20 parts of leech, 5 parts of ginger.The Chinese medicine composition of the treatment blood stagnancy due to deficiency of QI type apoplexy sequelae, reasonable selection Chinese medicine composition, above component convenient material drawing, cheap, curative effect is reliable, and long-term taking there will not be toxic side effect, effectively blood stagnancy due to deficiency of QI type apoplexy sequelae can be treated, improve patient.
Description
Technical field
The present invention relates to a kind of Chinese medicine, more particularly, to a kind of Chinese medicine group for being used to treat blood stagnancy due to deficiency of QI type apoplexy sequelae
Compound.
Background technology
Apoplexy sequelae refers to the sequelae that paralytic is suffered from, and mainly includes the crooked, decrease of memory of face mouthful, swallows
Difficult, speech is not smooth, body numbness even hemiplegia etc..Treat apoplexy sequelae and mainly use science diet, passive recovery
Take exercise and medicine auxiliary treatment, improve the factor of atherogenesis, reduce blood viscosity, anti-tampon shape again
Into preventing illness from further developing.
It is usually based on Western medicine, but to be to determine it is also obvious that there is drug resistance, drug effect at present for apoplexy sequelae
Can gradually it reduce, taking dose more and more significantly, to the toxic effect of patient body, is not suitable for long-term taking etc..Treatment by Chinese herbs
The disadvantages mentioned above of Western medicine is not present in apoplexy sequelae, and reasonable compatibility traditional Chinese medicinal components can not only mitigate patient's pain, therapeutic effect
Effective guarantee can be obtained.Therefore, it is necessary to develop a kind of Chinese medicine for treating apoplexy sequelae.
The content of the invention
It is an object of the invention to provide a kind of Chinese medicine composition for treating blood stagnancy due to deficiency of QI type apoplexy sequelae, can effectively it control
Blood stagnancy due to deficiency of QI type apoplexy sequelae is treated, and is had no toxic side effect.
In order to solve the above-mentioned technical problem, the technical solution adopted by the present invention is:One kind is treated after blood stagnancy due to deficiency of QI type apoplexy
Lose the Chinese medicine composition of disease, including following component in parts by weight:60 parts of the Radix Astragali, 18 parts of ginseng, 30 parts of jujube kernel, Radix Angelicae Sinensis 12
Part, 16 parts of radix bupleuri, 20 parts of rattletop of stir-fry, 10 parts of polygala, 16 parts of dried rehamnnia root, 15 parts of the bighead atractylodes rhizome, 12 parts of rubia grass, 10 parts of Exocarpium Citri Rubrum, teasel root 8
Part, 8 parts of edible tulip, 20 parts of leech, 5 parts of ginger.
During the medicine preparation, after above-mentioned each component is weighed by weight, pulvis is made and swallows, or adds water to cook two
It is secondary, take twice within 1st.
In the component of the present invention, the Radix Astragali has the effects such as enhancing immunity of organisms, anti-aging, decompression;Ginseng is considered as hundred
The king of grass, sweet micro- sweat, main tonifying five zang organs unsaturated vapor, soothe the nerves can expand capillary, stimulate circulation;Jujube kernel has flat
Liver and qi, the effect moistened the lung and nourish yin, can intelligence development breathe out surely, hearing-improing and eyesight improving;Radix Angelicae Sinensis has effects that promoting blood circulation and removing blood stasis, menstruction regulating and pain relieving;Bavin
It is always the important drugs for treating apoplexy recklessly, moreover it is possible to prevent and treat senile dementia;Fry rattletop can dispelling wind and relieving convulsion, control head wind headache, limbs
The diseases such as the not smoothgoing plug of numbness, hemiplegia, language;Polygala can tranquilize the mind and promote the intelligence, nourishing heart blood, relieving convulsion, to deficiency of heart-QI, the five internal organs are not enough, brain
Wind headache, forgetful it be scared, absent-minded have good curative effect;Dried rehamnnia root can be enriched blood with nourishing Yin and promoting production of body fluid, cool blood, be passed through less for blood
Close, the disease such as the micro- Huang of the deficiency of blood;The bighead atractylodes rhizome has calm, expansion blood vessel, anticoagulant, improves immunity, anti-oxidant and other effects;Rubia grass is dispelled
The stasis of blood is stimulated the menstrual flow, effect of activating blood circulation;Exocarpium Citri Rubrum energy row dissipating bind, straight trip decline, and are sharp gas key medicine;Gas can be discontinuously helped, blood vessels are adjusted, it is raw
New blood, breaks extravasated blood, long term usage energy benefiting energy;Edible tulip can be with clearing heat and detoxicating, dispersing swelling and dissipating binds, treatment ulcer malignant sore;Leech, which has, to be controlled
The effects such as apoplexy, hypertension, desilting is treated, with very high medical value;Ginger warming spleen and stomach for dispelling cold, Back to Yang Tongmai, can invigorating qi and refreshing.
The Chinese medicine composition of the treatment blood stagnancy due to deficiency of QI type apoplexy sequelae, reasonable selection Chinese medicine composition, above component
Convenient material drawing, cheap, curative effect is reliable, and long-term taking there will not be toxic side effect, can be effectively to blood stagnancy due to deficiency of QI type apoplexy
Sequelae is treated, and improves patient.
Embodiment
Below in conjunction with specific embodiment, technical scheme is clearly and completely described, it is clear that retouched
The embodiment stated is only a part of embodiment of the invention, rather than whole embodiments.Based on the embodiment in the present invention, sheet
The every other embodiment that field those of ordinary skill is obtained under the premise of creative work is not made, belongs to the present invention
The scope of protection.
The Chinese medicine composition of the treatment blood stagnancy due to deficiency of QI type apoplexy sequelae, including following component in parts by weight:The Radix Astragali
60 parts, 18 parts of ginseng, 30 parts of jujube kernel, 12 parts of Radix Angelicae Sinensis, 16 parts of radix bupleuri, fry 20 parts of rattletop, 10 parts of polygala, 16 parts of dried rehamnnia root, the bighead atractylodes rhizome
15 parts, rubia grass 12 parts, 10 parts of Exocarpium Citri Rubrum, 8 parts of teasel root, 8 parts of edible tulip, 20 parts of leech, 5 parts of ginger.
After said components are weighed accurately, the weight ratio of the weight twice, added water twice that adds water and Chinese medicine is 9:1、7:1 decocts
Decoction is cooked into, is taken twice within 1st;Medicine can also be worn into powdery, and water is swallowed.
Curative effect is carried out from medicine prepared by technical solution of the present invention, 88 blood stagnancy due to deficiency of QI of certain county people's hospital are chosen
The patient of type apoplexy sequelae is verified, is drunk twice within one day, continuous use three months.The result is as follows:
Patient numbers | Treat efficiently individual quantity | The invalid number for the treatment of | Total effective rate |
88 people | 81 people | 7 people | 92.1% |
By above treatment results it can be found that the treatment blood stagnancy due to deficiency of QI type Chinese medicine composition is to blood stagnancy due to deficiency of QI type apoplexy sequelae
With good improvement, total effective rate is more than 92%.
Finally it is pointed out that above embodiment is only the more representational example of the present invention.Obviously, it is of the invention
Above-mentioned embodiment is not limited to, there can also be many deformations.Every technical spirit according to the present invention specific reality to more than
Any simple modification, equivalent variations and modification that the mode of applying is made, are considered as belonging to protection scope of the present invention.
Claims (1)
1. a kind of Chinese medicine composition for treating blood stagnancy due to deficiency of QI type apoplexy sequelae, it is characterized in that the Chinese medicine composition is included with weight
The following component of part meter:60 parts of the Radix Astragali, 18 parts of ginseng, 30 parts of jujube kernel, 12 parts of Radix Angelicae Sinensis, 16 parts of radix bupleuri, 20 parts of rattletop of stir-fry, polygala 10
Part, 16 parts of dried rehamnnia root, 15 parts of the bighead atractylodes rhizome, 12 parts of rubia grass, 10 parts of Exocarpium Citri Rubrum, 8 parts of teasel root, 8 parts of edible tulip, 20 parts of leech, ginger 5
Part.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710317112.3A CN107308421A (en) | 2017-05-08 | 2017-05-08 | A kind of Chinese medicine composition for treating blood stagnancy due to deficiency of QI type apoplexy sequelae |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710317112.3A CN107308421A (en) | 2017-05-08 | 2017-05-08 | A kind of Chinese medicine composition for treating blood stagnancy due to deficiency of QI type apoplexy sequelae |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107308421A true CN107308421A (en) | 2017-11-03 |
Family
ID=60184847
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710317112.3A Pending CN107308421A (en) | 2017-05-08 | 2017-05-08 | A kind of Chinese medicine composition for treating blood stagnancy due to deficiency of QI type apoplexy sequelae |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107308421A (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103933200A (en) * | 2014-01-14 | 2014-07-23 | 李承文 | Traditional Chinese medicine composition for treating apoplexy sequela |
CN104208643A (en) * | 2014-09-25 | 2014-12-17 | 刘建忠 | Chinese medicine for treating hemiplegia and preparation method thereof |
-
2017
- 2017-05-08 CN CN201710317112.3A patent/CN107308421A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103933200A (en) * | 2014-01-14 | 2014-07-23 | 李承文 | Traditional Chinese medicine composition for treating apoplexy sequela |
CN104208643A (en) * | 2014-09-25 | 2014-12-17 | 刘建忠 | Chinese medicine for treating hemiplegia and preparation method thereof |
Non-Patent Citations (3)
Title |
---|
万春等: "补中益气汤治疗中风后遗症32例", 《中医研究》 * |
李国琳等: ""补中益气汤加三七冰片治疗中风痴呆病40例"", 《四川中医》 * |
杨生贵,杨发坤: "中风病治疗体会", 《甘肃中医学院学报》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103536889B (en) | One is treated senile chronic tracheitis and is merged emophysematous Chinese medicine decoction | |
CN101229267A (en) | Medicine compounds for pulmonary and rheumatic heart disease and preparing method thereof | |
CN105343645A (en) | External traditional Chinese medicine ointment for treating verruca plana | |
CN103385941B (en) | Chinese herbal medicine analgesic moxibustion | |
CN104383460A (en) | Traditional Chinese medicine powder for treating insomnia | |
CN103230535A (en) | Medicinal liquor with function of activating collaterals to ease pain | |
CN106511773A (en) | Traditional Chinese medicine composite for treating dental ulcer | |
CN105878627A (en) | Traditional Chinese medicine formula for treating myopic disease | |
CN107308421A (en) | A kind of Chinese medicine composition for treating blood stagnancy due to deficiency of QI type apoplexy sequelae | |
CN104547916A (en) | Traditional Chinese medicine decoction for treating coronary heart disease | |
CN103055172A (en) | Chinese medicinal composition for treating leucoderma | |
CN104258295A (en) | Traditional Chinese medicine decoction for treating lymphoma | |
CN103990019A (en) | Traditional Chinese medicine preparation for treating light-headedness | |
CN107412512A (en) | A kind of pharmaceutical composition for treating varix of lower limb | |
CN103340975A (en) | Traditional Chinese medicine for treating duodenal ulcer | |
CN103893675A (en) | Traditional Chinese medicinal preparation for treating epigastric pain | |
CN106728973A (en) | A kind of Chinese medicinal capsule for treating cervical spondylopathy | |
CN106177663A (en) | A kind of Chinese medicine composition for treating verruca plana | |
CN106511698A (en) | Traditional Chinese medicine for treating hypertension | |
CN101596299A (en) | A kind of Chinese medicine pill for the treatment of precancerous lesions of chronic atrophic gastritis | |
CN105412612A (en) | Medicine for treating insomnia | |
CN106215040A (en) | A kind of Chinese medicine composition treating asthma | |
CN105125949A (en) | Chinese drug preparation for treating syndromes after cholecystotomy | |
CN104740193A (en) | Traditional Chinese medicine composition for treating neck-shoulder muscle strain syndrome and preparation method of traditional Chinese medicine composition | |
CN104623549A (en) | Traditional Chinese medicine preparation for treating costal chondritis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20171103 |